Directed Evolution Reveals the Binding Motif Preference of the LC8/DYNLL Hub Protein and Predicts Large Numbers of Novel Binders in the Human Proteome by Rapali, Péter et al.
Directed Evolution Reveals the Binding Motif Preference
of the LC8/DYNLL Hub Protein and Predicts Large
Numbers of Novel Binders in the Human Proteome
Pe ´ter Rapali
1,L a ´szlo ´ Radnai
1,D a ´niel Su ¨veges
1, Veronika Harmat
2,3, Ferenc To ¨lgyesi
4, Weixiao Y.
Wahlgren
5, Gergely Katona
5,L a ´szlo ´ Nyitray
1*,G a ´bor Pa ´l
1*
1Department of Biochemistry, Eo ¨tvo ¨sL o r a ´nd University, Budapest, Hungary, 2Institute of Chemistry, Eo ¨tvo ¨sL o r a ´nd University, Budapest, Hungary, 3Protein Modeling
Research Group, Hungarian Academy of Sciences, Eo ¨tvo ¨sL o r a ´nd University, Budapest, Hungary, 4Institute of Biophysics and Radiation Biology, Semmelweis University,
Budapest, Hungary, 5Department of Chemistry, University of Gothenburg, Gothenburg, Sweden
Abstract
LC8 dynein light chain (DYNLL) is a eukaryotic hub protein that is thought to function as a dimerization engine. Its
interacting partners are involved in a wide range of cellular functions. In its dozens of hitherto identified binding partners
DYNLL binds to a linear peptide segment. The known segments define a loosely characterized binding motif: [D/S]-4K-3X-2[T/
V/I]-1Q0[T/V]1[D/E]2. The motifs are localized in disordered segments of the DYNLL-binding proteins and are often flanked by
coiled coil or other potential dimerization domains. Based on a directed evolution approach, here we provide the first
quantitative characterization of the binding preference of the DYNLL binding site. We displayed on M13 phage a naı ¨ve
peptide library with seven fully randomized positions around a fixed, naturally conserved glutamine. The peptides were
presented in a bivalent manner fused to a leucine zipper mimicking the natural dimer to dimer binding stoichiometry of
DYNLL-partner complexes. The phage-selected consensus sequence V-5S-4R-3G-2T-1Q0T1E2 resembles the natural one, but is
extended by an additional N-terminal valine, which increases the affinity of the monomeric peptide twentyfold. Leu-zipper
dimerization increases the affinity into the subnanomolar range. By comparing crystal structures of an SRGTQTE-DYNLL and
a dimeric VSRGTQTE-DYNLL complex we find that the affinity enhancing valine is accommodated in a binding pocket on
DYNLL. Based on the in vitro evolved sequence pattern we predict a large number of novel DYNLL binding partners in the
human proteome. Among these EML3, a microtubule-binding protein involved in mitosis contains an exact match of the
phage-evolved consensus and binds to DYNLL with nanomolar affinity. These results significantly widen the scope of the
human interactome around DYNLL and will certainly shed more light on the biological functions and organizing role of
DYNLL in the human and other eukaryotic interactomes.
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Introduction
The LC8 dynein light chain (DYNLL in mammals) is a highly
conserved 10 kDa protein that was originally described as a
potential cargo binding adapter of both dynein and myosin 5a
motor proteins and as an inhibitor of the neuronal NO-synthase
enzyme (reviewed in [1]). Subsequent studies demonstrated that it
binds to and regulates dozens of other proteins unrelated to the
cytoskeletal motors. It is now considered to be a eukaryotic hub
protein [2,3]. Its known binding partners are involved in highly
diverse cellular processes including apoptosis (BH3-only proapop-
totic proteins, Bim and Bmf [4,5]), DNA repair (e.g. P53BP1 [6]),
transcriptional regulation (e.g. NRF-1 [7]), nuclear transport (e.g.
Nup159 and Pak1 [8,9]), viral infection (e.g. lyssavirus P protein
[10]) or cancer development (e.g. Pak1 [11]). Several DYNLL
binders function in the presynaptic cytomatrix (e.g. Bassoon [12])
and in the postsynaptic density (e.g. GKAP [13] and KIBRA [14]).
By gene knockout and knockdown experiments DYNLL has been
shown to be an essential protein in Drosophila and C. elegans [15,16].
Vertebrate genomes contain two DYNLL paralogs DYNLL1 and
DYNLL2 which share 93% sequence identity at the protein level.
It is still controversial whether the two isoforms have disparate
cellular functions. In some studies DYNLL1 and DYNLL2 were
found to bind in vivo specifically to the dynein and myosin 5a
complexes, respectively [4,17,18], but other studies do not support
this view [19]. The two isoforms have identical in vitro binding
characteristics to their interacting proteins studied so far [18,20]
Apo- and ligand-bound structures, determined both by X-ray
diffraction and NMR spectroscopic studies, revealed that DYNLL
forms a homodimer possessing two identical ligand binding sites.
In DYNLL a swapped b-sheet dimer interface is formed. In the
complexes two 7-residue peptides bind to parallel grooves at the
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[18,21,22,23,24,25,26,27]. Since the DYNLL-binding linear
peptide motifs are generally located in intrinsically disordered
regions of the partner proteins and bind to DYNLL as a short b-
strand they could be considered as b-MoRE (molecular recogni-
tion element) [28,29]. DYNLL-binding motifs are often flanked by
coiled coil or other dimerization domains. DYNLL could function
upon complex formation as a ‘‘molecular glue’’ by promoting and
stabilizing the dimeric structure and in this way regulating the
function of its binding partners [30,31,32].
The diverse DYNLL binding motifs were traditionally divided
into two loose consensus sequence classes, [K/R]-3X-2T-1Q0T1 and
G-2I-1Q0V1D2 [33,34]. Moreover, a few known partners have non-
canonical motifs lacking the conserved Gln such as myosin 5a (D-
5D-4K-3N-2T-1M0T1D2) [30,32], p21-activated kinase (Pak1) (R-5D-
4V-3A-2T-1S0P1I2)[35] andGRINL1(E-5T-4R-3E-2I-1G0V1G2)[36].
In the crystal structure of canonical complexes the side chain of the
central glutamine (position 0) caps the N-terminal end of the second
a-helix, while the side chains of residues at positions +1, 21 and 23
interact with the hydrophobic interior of the binding groove and
someofthesealsoparticipateinH-bondsformedbystructuralwater
molecules [22,23,24,26]. The importance in binding of the
conserved glutamine and of the two flanking residues was
demonstrated by mutational studies [37]. In the non-canonical
Pak1 sequence, a key H-bond network was identified that
compensates for the lack of the conserved glutamine [35]. The
functional significance of the binding motif classes has not been
demonstrated yet. Previous studies suggest a hierarchy or
continuum of binding affinities (,1–50 mM) depending on the
actual sequence of the motifs [20,35]. On the other hand, different
motif classes could achieve roughly the same binding affinities
through different thermodynamic mechanisms [20]. It is important
to note that many of the binding partners were shown to exist as
homodimers therefore DYNLL most likely forms dimer-dimer
complexes with its partners [24,30,35]. In fact, binding of bivalent
ligands shows a considerable avidity effect; affinity of a dimeric
myosin 5a fragment has been recently reported to be ,40 nM [20].
In this work we applied phage display in order to determine the
characteristic amino acid preferences of individual peptide motif
positions. Seven positions in a naı ¨ve peptide-phage library were
totally randomized, while the conserved glutamine was fixed. The
in vitro selected consensus sequence is similar to the natural one,
but is extended by an additional binding determinant, a Val,
which increases the affinity twentyfold. Dimerization through a
Leu-zipper further increases the affinity into the subnanomolar
range. Structural basis of the affinity enhancement was addressed
by solving the crystal structure of two DYNLL-peptide complexes.
Using the in vitro evolved sequence pattern we performed a
bioinformatics analysis to identify potential novel DYNLL-binding
proteins. By focusing our search on intrinsically disordered regions
of intracellular segments of the human proteome we identified 110
potential novel DYNLL binding partners. Interestingly, among
several promising candidates, we identified a human protein,
EML3 (also termed as EMAP-3, Uniprot: Q32P44) that contains
the phage-selected consensus sequence located in a disordered
region. With in vitro studies we verified that EML3 binds to
DYNLL with high affinity.
Results
Directed evolution of DYNLL-binding motif from
bivalently displayed naı ¨ve peptide library
We combined all 41 hitherto identified canonical DYNLL-
binding motifs representing both previously established classes
from 33 eukaryotic interacting proteins (Table S1) to define the
following 7-mer linear motif: ([D/S]-4K-3X-2[T/V/I]-1Q0[T/
V]1[D/E]2. Published affinities of the natural binding peptides
are in the micromolar range (0.75 mM,Kd,50 mM) [20,38,39].
We aimed to elucidate the thermodynamically driven charac-
teristic amino acid preferences of individual motif positions. To do
so, we applied directed evolution by selecting DYNLL1 binders
from a phage displayed peptide library. Before building the library
we determined the optimal display format by displaying the
strongest known binding peptide (Kd=0.75 mM) from Bmf [20]
on M13 phage. The Bmf peptide (E-5D-4K-3A-2T-1Q0T1L2) was
fused to an N-terminal Flag-tag and displayed monovalently on
the p3 and also multivalently on the p8 coat protein. Phage-ELISA
using immobilized anti Flag-tag antibody demonstrated successful
display in both cases. However, binding to immobilized GST-
fused DYNLL1 was hardly detectable (data not shown). DYNLL
isoforms are homodimers having two identical peptide binding
sites [22,23,24,26]. In order to mimic the natural dimer binding to
dimer mechanism [20,24,30,40], we inserted a Leu-zipper motif
from GCN4 between the Flag-tagged Bmf peptide and the p3 coat
protein and displayed the peptide in a bivalent format (see
Figure 1). A similar dimerizing approach was published by Fuh
and colleagues [41,42]. In that study the authors applied
competition phage-binding assays and demonstrated the bivalent
display through its apparent affinity boosting avidity effect that, as
expected, occurred only on surface immobilized targets as opposed
to solvent-phase targets. In our case, due to the same effect, Leu-
zipper based dimerization resulted in detectable binding to GST-
fused DYNLL1. Based on simple modeling studies we produced
three variants with 4-mer (GGSG), 6-mer (GGSGGS) and 8-mer
(GGSGGSGS) linker, respectively, in order to optimize the
geometry of the bivalent binding. In binding assays the 4-mer
linker was the best one. Since both too low or too high
transcription levels decrease display efficiency [41,43], we tried
to optimize the expression level of the originally used pTac
promoter by inducing it at various IPTG concentrations. As low as
10 mM IPTG concentration had deleterious effect on display
(Figure S1) suggesting that even the leakage of the strong pTac
promoter might afford higher than optimal transcription level.
Therefore we replaced the pTac promoter with the weaker PhoA
promoter [42], which increased the display level about 30-fold
(Figure S1) allowing for efficient peptide-library display.
The library design fixed the most conserved glutamine at
position 0, while in all other positions from 25 to 2 allowed the
occurrence of all 20 amino acid residues: X-5X-4X-3X-2X-
1Q0X1X2 (Figure 1). Note that we extended the original motif
with one extra position (position -5) at the N-terminus. The library
contained 2.1610
10 individual clones. Total randomization of 7
amino acid positions by degenerate (NNK) codons results in a
theoretical diversity of 32
7=3.4610
10 variants. Our library size
approaches the theoretical one suggesting that most variants were
indeed present in the starting repertoire. In the third panning
cycles the enrichment was 100 fold. Individual clones from this
selection cycle were tested in phage-ELISA experiments for
DYNLL1-binding and the DNA of 36 positive clones was
sequenced yielding 25 unique sequences (Table S2). From the
anti Flag-tag selection 32 ELISA positive clones were sequenced
and 30 were unique (Table S3). This set was used for subtracting
the effects of display bias from the DYNLL1-selected set.
The in vitro evolved binding motif
After display-bias normalization we illustrated the amino acid
preferences of individual binding positions in the form of a
sequence logo using the WebLogo program [44]. In Figure 2 the
Phage Display-Evolved DYNLL Binding Peptides
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known naturally evolved DYNNL1 binding peptides (listed in
Table S2). Generally, the two logos are similar, but there are a few
characteristic differences. In the 21 and +1 positions both logos
show strong conservation and marked preference for threonine. At
position +2 there is a lower level conservation and slight preference
for a negative charge (Glu, Asp) in both sets. There are similarities
at the moderately conserved positions 22 and 23 as well. At
position 22 mostly small residues are selected (Gly, Ala), while at
position 23 there is a preference for positively charged residues
(Arg, Lys). The characteristic differences appear at positions 24
and 25. In the natural binding peptides at position 24a
negatively charged Asp is the most frequent amino acid, which is
absent from the in vitro selected pool. The most striking difference
emerged at position 25, where the known natural binding
peptides show lack of preference, while the in vitro evolved set
presents significant non-randomness. Here mostly apolar residues
(Val, Met, Ile, Leu) or polar residues with long aliphatic side chain
portion were selected (Arg, Lys), with the most preferred residue
being Val.
Binding properties of the in vitro evolved consensus
peptide 2 the significance of Val-5
Binding parameters of the in vitro evolved Ac-VSRGTQTE and
naturally evolved Ac-DKSTQTD consensus peptides were
determined by isothermal titration calorimetry (ITC). Synthetic
peptides were used and N-terminal acetylation was applied to
better mimic a non-terminal peptide motif by avoiding the
positively charged N-terminus. In order to elucidate the particular
contribution of Val-5 to the binding affinity, several control
peptides were produced. The in vitro evolved Val-5 was replaced
with a glycine (Gly-5) to assess side chain function. In a further
Figure 1. Bivalent phage display. Map of the pPFBL-p3 phagemid vector (A), the expression cassette of the bivalent pPF-Lib-p3 library construct
(B) and the schematic presentation of the bivalent display format (C).
doi:10.1371/journal.pone.0018818.g001
Figure 2. Sequence logos of naturally evolved and in vitro
evolved binding motifs. Position heights represent the degree of
conservation. Letter heights indicate normalized amino acid propor-
tions. (A) Sequence logo calculated from 41 known natural binding
motifs listed in Table S1 and (B) from phage selected DYNLL-binding
clones listed in Table S2. Similar colors indicate similar chemical
properties [44].
doi:10.1371/journal.pone.0018818.g002
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an acetate group (Ac-5) to assess the function of the amide group at
position 25. The same variations of Val-5, Gly-5 or Ac-5 were also
introduced in the framework of the naturally evolved consensus
peptide. DYNNL1 binding of all six variants was analyzed by ITC.
The results are illustrated in Figure 3 and the binding parameters
are summarized in Table 1. In all measurements the stoichiometry
of binding was 1:1 (2 peptides binding to one homodimer
DYNNL1). The binding was enthalpy-driven and was accompa-
nied with unfavorable entropy change. Ac-5 versions of both the
natural and the in vitro evolved consensus peptide had binding
affinities in the micromolar range. Replacing the acetyl group with
Gly-5 led to a tenfold affinity increase with both peptides. This was
due to a favorable change in binding enthalpy contribution
suggesting that the main chain at position 25 participates in
stabilizing molecular interactions. Replacing Gly-5 with a Val
Figure 3. Thermodynamic binding properties of natural and in vitro evolved motifs determined by isothermal titration calorimetry.
Data for natural consensus (Ac-DKSTQTD) and its two control peptides and data for phage selected consensus (Ac-VSRGTQTE) and its two control
peptides are shown in A and B, respectively.
doi:10.1371/journal.pone.0018818.g003
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frame of the in vitro evolved peptide it was due to a favorable
binding enthalpy change suggesting new stabilizing interactions
through the Val side chain.
Peptide dimerization increases binding affinity
Homodimer structure of DYNLL1 allows for simultaneous
binding of two peptides resulting in an avidity effect provided that
the peptides are presented in dimer format [20,24]. This effect was
utilized in the in vitro evolution process by displaying the peptide
library in a Leu-zipper fused bivalent form. We tested how the
same bivalency affects binding properties of the peptides.
Dimerization of the Gly-5 containing peptides enhanced their
affinity compared to the monomeric versions (see in Table 1). In
case of the naturally evolved consensus the improvement was 80-
fold, while for the in vitro evolved consensus it was over 500-fold.
Interestingly, for the in vitro evolved peptide this improvement was
solely due to a less unfavorable entropy term, suggesting that pre-
dimerization of the peptide decreases the entropy penalty of
complex formation. In case of the naturally evolved consensus
peptide the affinity improvement was due to a combination of
more favorable enthalpy and less unfavorable entropy terms. In
both cases the affinities were driven to the low nanomolar range,
where ITC measurements reach the dynamic range limit of the
method [45] suggesting that affinities of the dimeric peptides can
be even higher. Dimerization of the Val-5 containing naturally
evolved and in vitro evolved peptides resulted in a tenfold
improvement of their monomeric affinities resulting similar low
nanomolar values already seen for the Gly-5 peptides. Again, the
corresponding dissociation constants might be significantly lower.
Structural significance of position 25
For crystallographic studies we used DYNLL2 because its
binding site and binding properties are identical to those of
DYNLL1 [20], but it lacks a free surface exposed cysteine and
hence is chemically more stable during crystallization. In order to
understand the positive contribution of Val-5 to DYNLL binding
we crystallized and analyzed the DYNLL2 complexes formed with
the monomeric Ac-SRGTQTE peptide and with the Leu-zipper
dimerized GSVSRGTQTE peptide (where the first two residues
originate from the recombinant construct) (Table S4). We also
made multiple attempts to grow crystals of acceptable quality from
the Ac-VSRGTQTE peptide-DYNLL2 complex. Initially, this
complex was prepared similarly to the Ac-SRGTQTE peptide-
DYNLL2 complex (see Experimental Procedures), but it showed
markedly different behavior. After 5 minutes thousands of tiny
crystal groups composed of dozens of small needles appeared.
Several thousands of conditions were tested, but even the best
crystals diffracted only around 10 A ˚.
Crystal structure of the Ac-SRGTQTE-DYNLL2 complex was
solved and refined at 1.31 A ˚ resolution (Figure 4A). The
asymmetric unit contains four chains forming two dimers. In the
resulting electron density map the bound Ac-SRGTQTE-peptide
could be clearly identified. All residues were in the most favored
Ramachandran region except for Asn51, which has a positive Q
angle, as in all other DYNLL structures [18,21,22,23,24,25,26,27].
Similar to the human DYNLL/Swa peptide complex (PDB entry
3e2b), each dimer contains two five-stranded b sheets, with four
strands from one subunit and a fifth strand crossed over from the
other subunit. One side of each sheet is flanked by two helices
while the other side forms the dimer interface. Both Ac-
SRGTQTE peptides bind identically to their symmetry related
binding sites forming a sixth b strand in the grooves created at the
dimer interface (Figure 4F). The side chains of residues Thr1, Thr-
1 and Arg3 of the peptide project toward the interior of DYNLL2,
into a deep hydrophobic groove lined by aromatic DYNLL
residues Phe73, Tyr75, Tyr77, Phe62 and Tyr65 (Figure 4D).
Crystal structure of the complex formed between DYNLL2 and
Leu-zipper dimerized GSVSRGTQTE peptide complex was
solved and refined to 2.9 A ˚ resolution (Figure 4B). Overall
conformation of the DYNLL2 dimer and the binding region
highly resembles to that of the Ac-SRGTQTE complex structure.
Individual DYNLL2 dimers can be fitted with an RMSD in the
range of 0.38–0.66 A ˚ for the DYNLL2 backbone atoms and with
an RMSD in the range of 0.42–0.61 A ˚ for the peptide (Figure 4C).
A few side chains outside of the motif segment were not resolved in
the electron density map perhaps due to inherent flexibility. The
binding region was well resolved due to conformational stabiliza-
tion by molecular contacts. The DYNLL2 dimer and the
interactions within the two binding grooves are symmetric. In
contrast, the coiled coil region of the Leu-zipper diverges from the
symmetry axis of the complex due to asymmetric crystal contacts
of its two a-helices. Different backbone conformations of the four-
residue linkers in the two peptides as well as their elevated thermal
factors indicate that the linkers are flexible (Figure 4B) suggesting
that the Leu-zipper does not interfere with the binding interaction.
The bound SRGTQTE segment of the peptide preserves the 5
backbone hydrogen bonds of the b-sheet interaction and the 11
additional hydrogen bonds of the high resolution complex
structure (Figure 4F). Favorable interactions of the additional
Val-5 residue highlight direct and indirect structural basis of its
contribution to increased binding affinity. The Val-5 residue
extends the b-sheet establishing two backbone hydrogen bonds
(Figure 4G), while its side chain is accommodated into a shallow
pocket formed partially by the His68 imidazole ring, which is also
involved in binding the Arg-3 side chain through an H-bond
(Figure 4E). The recombinant construct derived Gly-7 and Ser-6
residues do not interact directly with DYNLL2.
In the crystal of the dimer-to-dimer complex, due to crystal
packing, neighboring GSVSRGTQTE-DYNLL2 units form
antiparallel b-sheet structures. We speculate that the same
antiparallel b-sheet structures form in case of the Ac-
VSRGTQTE-DYNLL2 complex resulting in the observed almost
instantaneous crystal formation. If this is the case, presence of the
Leu-zippers would slow down the association of the resulting long
Table 1. Thermodynamic analysis of DYNLL-binding
interactions.
Partner Kd (mM)
DH
(kJ mol
21)
-TDS
(kJ mol
21)
Ac-DKSTQTD 5.6 248.8 18.9
Ac-GDKSTQTD 0.56 270.3 34.4
Ac-VDKSTQTD 0.07 265.4 24.8
dimeric-GSGDKSTQTD* ,0.007 276.2 ,29.4
dimeric-GSVDKSTQTD* ,0.009 288 ,42.0
Ac-SRGTQTE 15.2 248.6 21.0
Ac-GSRGTQTE 1.64 269.7 36.5
Ac-VSRGTQTE 0.08 275.6 35.0
dimeric-GSGSRGTQTE* ,0.003 269.6 ,20.6
dimeric-GSVSRGTQTE* ,0.007 264.9 ,17.6
EML3 (8-94) 0.05 232.4 9.465
*Data reach the dynamic range limit of the ITC method.
doi:10.1371/journal.pone.0018818.t001
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GSVSRGTQTE proceeds at a much lower rate.
Predicting novel DYNNL binding partners based on the
phage-selected sequence set
It was previously shown that display bias-normalized affinity-
selected amino acid frequencies correlate with binding energy
contributions of the selected amino acid residues [46,47,
48,49,50,51]. This finding together with the assumption that
amino acids in a linear motif contribute independently to the
binding affinity, led to the design of a simple scoring system (see
Materials and Methods). The general logic of binding motif
prediction is illustrated as a flowchart in Figure 5. When an
octapeptide segment is aligned with the phage-selected sequence
logo, at each position the given amino acid type of the peptide gets
scored based on the display-bias normalized frequency of the same
amino acid type in the selected pool. The eight positional score
values are summed up to give the final score (see Materials and
methods). This system is suitable for the 7 fully randomized
positions but is incompatible with the fixed Gln at position zero.
Giving zero score at this position for the lack of a Gln would have
underestimated such motifs compromising the entire scoring
system. Therefore we analyzed only those segments that do have
a Gln at position zero and we did not give a score to this position.
This way the minimal score, zero is given to octapeptides that out
of the fixed Gln do not contain any residue present in the selected
set. The maximal score, 367 is given to the octapeptide
representing the consensus of the selected pool.
We restricted our search to cytoplasmic and predictably
disordered regions of the human proteome since known DYNLL
Figure 4. Crystal structure of Ac-SRGTQTE – DYNLL2 (A, C, D and F) and Leu-zipper dimerized VSRGTQTE – DYNLL2 complex (B, C, E
and G). Peptides bound to DYNLL adopt similar conformation, see alignment in C. As shown in B the Leu-zipper dimerized VSRGTQTE peptides lay
into two parallel binding grooves on DYNLL2 forming a dimer-dimer complex. Colors from red to blue correspond to high and low B-factors,
respectively (from 131 to 48). The GGSG linker between the binding motif and the Leu-zipper appears to be flexible. Side chain interactions between
the peptides and the binding grove of DYNLL2 are shown in D and E. Side chains of DYNLL2 having at least one atom within 4 A ˚ distance from the
peptide are shown as sticks. F and G are rotated versions (by approximately 90u along the axes of the binding motifs) of D and E, respectively, and
show that the peptides bind to DYNLL2 in a b-strand conformation. Interestingly, the interaction is partially mediated by H-bridges of several buried
structural waters represented as red spheres in D and E. Comparing F and G shows that the backbone of Val-5 forms one additional hydrogen bond,
while E and G illustrate that its side chain interacts with DYNLL2 His68. Details of this interaction are highlighted by orange areas.
doi:10.1371/journal.pone.0018818.g004
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distribution of the scores from 0 to 367 shows a nearly continuous,
exponentially decaying profile (Figure 6A.). The score distribution
of known binding motifs (Table S1) shows that: i) the two motif
families, [K/R]-3X-2T-1Q0T1 and G-2I-1Q0V1D2 are separated
from each other, the former having higher scores suggesting that
members of this family are closer to the thermodynamic binding
optimum; and ii) members of the [K/R]-3X-2T-1Q0T1 family are
dispersed in the high score region. Considering these as inner
controls their distribution indicates that the scoring system is
appropriate to predict novel partners.
A fundamental question was how to set the cutoff score value in
order to define a set of predicted novel binders depleted in false
positives. The global decaying trend of the probability density
function of scores is dictated by simple statistical rules. Starting
with an arbitrary sequence pattern for which no binding protein
exists in the human proteome the same global trend of scores
would apply. We argue that in case of a sequence pattern for
which a corresponding binding protein does exist, natural selection
should drift the proportion of high-score motifs away from the
stochastically expected values. Following this logic we used a
bootstrap analysis to determine the statistically driven baseline of
the probability distribution as follows. We produced one thousand
different scoring matrices where the positional amino acid
frequencies were kept the same as in the real phage-selected
matrix, but the positions were scrambled. Out of these thousand
scrambled patterns only a few if any might coincidentally represent
preference of an existing protein binding site and that is why these
can be used as a control set. We divided the density values
obtained from the DYNLL scoring with the corresponding mean
values from the scrambled scoring analysis. Below a score value of
220 the normalized density values were very close to one, but
above that score a statistically significant amount of high-score
motifs was detected (Figure 6B). Thus, we used the score value of
220 as a statistically verified cutoff to define our predicted dataset
of DYNLL binders. Proteins with motif(s) having a score 220 or
higher are considered to be potential DYNLL binders. Normal-
ized density values above score 220 indicates positive natural
selection that evolved a large number of DYNLL-binding
partners, which is expected for a hub protein.
Above the threshold level there are 242 motifs provided by 219
human proteins (listed in Table S5). Among these we find 8 out of
the 18 human DYNLL binding motifs for which the binding site
had already been identified. Interestingly, the highest possible
score i.e. the phage-selected consensus sequence is present once in
the human proteome in a microtubule associated protein called
EML3 [52], which has not yet been identified as a DYNLL
interacting partner. Our preliminary ITC studies verified that a
recombinant fragment of EML3 (residues 8–94) containing a
coiled coil domain and the in vitro evolved consensus motif binds to
DYNLL with a Kd of 50 nM (Figure S2).
Discussion
Most biological processes manifest through complex networks of
protein-protein interactions. In order to understand how a
network functions, one needs to identify all individual interactions
and determine their affinity and specificity. DYNLLs are hub
proteins recognizing a short linear motif, a b-MoRE in their
growing number of newly identified binding partners [2,37].
As residue conservation indicates functional importance,
comparison of natural binder sequences could in principle
elucidate the preference of their target binding site. However,
known natural sequences usually represent only a subset of all
existing binders biasing the observed sequence trend. Moreover,
natural evolution can select sequences based on several functions
in addition to binding, which complicates interpretation of an
observed pattern. A systematic study of the binding epitope
through single amino acid replacements can test the functional
importance of individual residues, but a complete analysis of even
a small binding site would require an impractically large number
of mutants. If the function relies on cooperating residues, mutation
combinations might require astronomical number of variants.
Directed evolution combines combinatorial mutagenesis with
functional selection and easily handles the above problems [53].
Diversity of our phage display library covered almost all possible
mutation combinations representing a near complete, unbiased
starting variant set. Our in vitro binding-selection combined with a
powerful display bias normalization revealed characteristic
sequence features, but we have to keep in mind that sequence
patterns obtained this way are the results of a thermodynamics-
driven binding-selection as opposed to a complex natural selection.
Based on the phage-selected binding pattern we applied a simple
scoring system combined with an untraditional baseline correction
approach to identify novel natural binding partners in the human
proteome.
Our library design covered both natural DYNLL-binding
sequence classes. Importantly, the 25 unique phage-selected
binders demonstrated that the two class characteristics can freely
mix. Thus, the existence of the two natural classes is not due to a
simple binding selection. It is either due to functional selections
other than DYNLL binding, or could simply be a sampling error
due to the limited number of known natural DYNLL binders. The
same conclusion was drawn from the in vitro thermodynamic
characterization of target sequences binding to DYNLL [20].
Figure 5. Flowchart of the binding partner prediction. Step A: all
non intracellular segments were excluded from the search. Step B:
sequences were split into overlapping eight residue segments; only
disordered segments with Gln at position 0 were scored. Step C: a score
was assigned (see Methods). Motifs with scores above threshold are
considered potential DYNLL binders. Step D: based on amino acid
composition, motifs were sorted into three classes with different
binding probabilities.
doi:10.1371/journal.pone.0018818.g005
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leads to an at least 100 fold increase in binding affinity. For
successful phage selection it was necessary to start with a
bivalently displayed peptide library. Nevertheless, the resulted
sequence pattern is relevant for the monovalent interaction as
well. Monomeric form of the consensus binding motif
(VSRGTQTE, Kd=0.08mM) binds tenfold tighter than the
strongest known natural DYNLL-binding sequence of the Bmf
protein (EDKATQTL, Kd=0.75mM) [20]. The natural and the
in vitro evolved sequence patterns had strong similarities at
positions 21a n d+1 localizing the TQT segment as a binding
epicenter. Additional similarities in preferences were found at
positions 23, 22a n d+2 suggesting that natural selection at these
positions is also governed mostly by DYNLL-binding. However,
compared to the TQT motif there is a relatively low level of
conservation at these positions in both sets indicating less
stringent requirement for a particular stereochemistry.
We identified two positions with characteristic differences
between naturally and in vitro evolved preferences. In nature Asp
is the most frequent residue at position24, but it is absent from the
in vitro selected population, where the second most frequent residue
in nature, Ser was selected. The anti Flag-tag antibody selected
clone set showed that peptides having Asp within the octamer
segment can be readily produced and displayed on phage.
Figure 6. Statistical analysis for threshold score determination. (A) Density distributions of scores. Dashed baseline is derived from average
values from 1000 randomized score sets (see Methods) while continuous line represents the in vitro selected scores. In the high score region (inset),
the phage-selected set yields higher frequencies than the randomized baseline set. (Error bars show standard deviation of frequencies in the
randomized sets). (B) The ratio of the density distribution functions of the scores. Above a threshold score value of 220 predicted DYNLL-binding
motif frequencies exceed stochastic frequencies obtained from the randomized set, therefore their ratio exceeds one.
doi:10.1371/journal.pone.0018818.g006
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a negative selection suggesting that in nature Asp-4 might have a
functional role other than DYNLL-binding. This model is
complicated by the fact that both in the nNOS-DYNLL [22] as
well as in the Pak1-DYNLL complex [35] Asp-4 appears to
contribute to the binding energy through H-bonding to Thr67 of
DYNLL. Interestingly, in the in vitro evolution derived Ac-
SRGTQTE-DYNLL2 complex Ser-4 participates in an analogous
H-bond with the same threonine.
The perhaps most important finding was that upon in vitro
evolution position 25 became much more conserved than
observed in nature. This suggested that position 25 could increase
DYNLL-binding affinity, but at least by the hitherto identified set
of natural DYNLL-binders this capacity is not generally utilized.
Indeed, ITC measurements verified that the most abundant in vitro
selected residue at this position, Val-5 significantly increases
binding affinity. Both the structure of the Leu-zipper dimerized
VSRGTQTE peptide - DYNLL2 complex as well as modeling
studies (unpublished results) showed that the apolar side chain of
Val-5 packs against His68 of DYNLL2, while the Val-5 main chain
forms two H-bonds with the protein further stabilizing the
antiparallel b-sheet structure of the complex. Our findings on
the functional role of Val-5 are in good agreement with the
pepscan analysis of Lajoix and colleagues [37] who found that a
Val or Ile at position 25 contributes to binding affinity.
One trivial explanation for nature rarely utilizing binding
potential of position 25 can be that natural evolution optimized
this interaction to have moderate affinity providing a dynamic,
transient nature. Although this might be the general rule, we
already identified one human protein, EML3 that contains a
perfect match of the in vitro evolved consensus. The sequence of the
DYNLL-binding motif is predicted to be located in a disordered
local environment with a nearby dimerizing coiled-coil segment.
These features increase the likelihood that EML3 is a novel
DYNLL binding protein. If so, EML3 is expected to bind DYNLL
with unusually high affinity suggesting that their interaction is less
transient than those so far identified. We have already shown that
a large fragment of EML3 binds tightly to DYNLL and studies are
in progress to further characterize the DYNLL-EML3 interaction
and to determine its possible function.
Based on the phage selection results we performed a bioinfor-
matic analysis on the human proteome to filter out a set of
potentially novel DYNLL binders. Had we aimed to cover all
known motifs we would have contaminated the filtered set with a
large number of false positives. Instead, we aimed to produce a
high-probability set with minimal amount of false positives even if
we would exclude several known DYNLL-binders (false negatives).
By applying a normalized scoring system we identified over two
hundred potential novel DYNLL binders. On the score density
function plot these exceed a statistically established threshold
suggesting that this set should contain few false negatives.
Moreover, novel members of this set are interspersed with known
natural binders, which validate our analyses (Table S1). On the
other hand, known binding partners getting lower than threshold
scores are ‘‘false negative’’ in this test. These low scores indicate
that factors other than thermodynamic adequacy of the octamer
motif can facilitate DYNLL binding. We have already demon-
strated that a ‘‘dimer binding to dimer’’ scenario providing avidity
is such a factor, which can increase apparent affinity by several
orders of magnitude [20]. Similar effect is expected when DYNLL
binding occurs in the context of a multimeric protein complex.
Extending the prediction to such cases requires more accurate
protein annotation and further experiments. For example,
although the coiled coil motif is the most studied predictable
dimerization engine and many DYNLL binders contain a nearby
coiled coil segment, it is yet to be elucidated how binding affinity
depends on the distance between a DYNLL binding site and the
coiled coil.
Each positional score reflects the frequency of the correspond-
ing amino acid at that position in the phage selected sequence set
therefore its value cannot be negative. This way the same zero
score is given for the absence of an amino acid irrespectively
whether it is missing for being energetically inert, or for being
inhibitory. This latter case should be given a negative penalty
score, but that is incompatible with our phage selection approach.
As an alternative solution we checked all cases where a predicted
motif position was given a zero score. We argued that if the residue
missing from the phage selected set exists at the same position in
known DYNLL binders, than it should be inert rather than
inhibitory. Moreover, based on the result of the pepscan study of
Lajoix et al [37] one residue type, proline is highly inhibitory, in
core positions (-4
th –0
th) it disrupts binding. In line with the above
arguments we sorted the predicted high score motifs into three
subclasses in descending order of reliability (Table S5): The most
likely binders, 110 binding motifs contributed by 98 proteins,
belong to class A where all residues of the motifs are present either
in the phage selected pool or in known DYNLL binding motifs
suggesting no energetic obstacles for binding. The 84 predicted
motifs belonging to 80 proteins in class B contain up to three
positions where the residue is missing from both the phage selected
and the known natural binding motif set. In class C containing 49
motifs from 49 proteins the presence of proline in core positions
may disrupt binding, like in the case of myosin 5a, where an
alternatively spliced form contains a proline in the -4
th motif
position, which renders the binding undetectable [30]. Although
these sequences are less likely to bind, favorable sequential
environment resulting in high overall score together with the
ability of multimerization may help to overcome the impairing
effect of prolines in some of these predicted motifs. We compared
the functional profile of the class A predicted pool to that of known
DYNLL binders (Figure 7) and found striking similarities.
Assuming that discovery of known binders was a representative
sampling from the pool of all binders the observed similarity
further enforces reliability of our prediction.
In this work we revealed a thermodynamically selected DYNLL
binding motif, which expanded our knowledge on the binding
preference of the partner proteins. The comparative structural and
functional analyses showed that in most interactions the phage-
evolved consensus motif mimics natural binders but also utilizes a
previously undetected binding capacity of DYNLL at the 25
position. Even considering only class A motifs we predicted about
one hundred novel DYNLL partners and this way significantly
widened the scope of the human interactome around DYNLL.
This large number of binders is in good agreement with the
proposed general dimerizing engine function of the DYNLL hub
protein. We have already shown that the highest scored EML3
protein is indeed a tight binder of DYNLL. Experimental
verification of binding capacity of a random sample of additional
predicted motifs is underway in our laboratory.
Phage display has been an exceptionally powerful approach to
characterize linear binding motif preference and in some cases
predict natural binders of several peptide recognition modules
including EH [54], PDZ [55,56,57,58,59,60], PTB [61], SH3
[62,63,64] and WW domains [65].
In this study we comprehensively characterized the linear motif
preference of the DYNLL hub protein and predicted novel
binders. We hope that our DYNLL binder classes will provide a
rich source of valuable information for research groups studying
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predicted interactions are verified the better we will understand
how DYNLL participates in organizing diverse protein networks
and we will also learn more about how these networks function.
Materials and Methods
All chemicals unless otherwise specified were purchased from
Sigma-Aldrich. DNA modifying enzymes were from Fermentas
and New England Biolabs.
Expression vector constructions
For bacterial GST-fused expression the DYNLL1 gene was
cloned into the pGEX4T-1 expression vector (Amersham)
between BamHIa n dNdeI restriction sites using PCR. For His-
tagged bacterial expression DYNLL1 and DYNLL2 (residues:
1–89, Uniprot accession numbers: P63167 and Q96FJ2,
respectively) were cloned into the pET-15b (Novagen) expres-
sion vector as previously described [20]. The leucine zipper
from yeast GCN4 peptide (residues: 250–281) was cloned
between BamHIa n dBglII sites into a modified pET expression
vector which allows N-terminal GST fusion and cleavage by
TEV protease.
Protein expression, purification and peptide synthesis
6xHis-tagged DYNLL1 and DYNLL2; the N-terminal GST-
tagged GCN4 leucine zipper-fused DYNLL-binding peptides and
the N-terminal GST-tagged DYNLL1 were expressed in E. coli
BL21(DE3)Star cells (Novagen). The cells were allowed to grow in
LB media up to OD600=1.5 at 37uC and induced overnight with
0.5 mM IPTG at 18uC. After affinity chromatography using GST-
Bind
TM Resin (Novagen) or Profinity
TM IMAC Ni-Charged Resin
(Bio-RAD), the N-terminal GST or 6xHis tags were removed by
proteolysis. In case of the GCN4 leucine zipper-fused DYNLL-
binding peptides TEV protease [66], while in case of DYNLL2,
thrombin was used. The DYNLL1, DYNLL2 and GST-tagged
DYNLL1 proteins were further purified by anion exchange
chromatography using HiTrapQ ion-exchange column (Amer-
sham) as previously described [30].
Short synthetic peptides were produced in-house using an ABI
431A Peptide Synthesizer and standard Fmoc chemistry. The N-
terminus of the peptides was acetylated.
The GCN4 leucine zipper-fused peptides and the synthetic
peptides were purified by RP-HPLC using Jupiter-300 5 mm C18
300 E 106250 mm column (Phenomenex). Peptide and protein
identities were confirmed by mass spectrometry. Protein concen-
trations were estimated by absorbance at 280 nm using calculated
molar extinction coefficients; concentration of peptides was
estimated by amino acid analysis.
Phagemid vector construction
The pS1602a phagemid [67] displaying human growth
hormone (hGH) on the p3 coat protein of the M13 phage
under the control of a pTac promoter was generously provided
by Genentech. This vector contains an NsiI site between the
signal peptide and the hGH coding sequence. Between the hGH
and the p3 protein coding segments there is a glycine-serine (G/
S) linker coding segment, which does not contain unique
restriction enzyme cleavage site. A unique KpnI site was
introduced to the beginning of the G/S linker by Kunkel
mutagenesis [68] resulting the phagemid, pG2B. Then, in
several cloning steps using synthetic adaptors, primers and PCR
reactions, the pTFBL-p3 vector was produced. This vector
contains a pTac promoter, a malE signal peptide and a p3
coding segment from pS1602a [67]. Between the signal peptide
a n dt h ep 3s e g m e n ti tc o n t a i n saF L A G - t a g( D Y K D D D D ) ,a5
residue G/S linker, an 8 residue (EDKATQTL) DLC-binding
peptide from the Bmf protein (residues: 66–73; Uniprot
accession number Q96LC9) [5], a 4 residue G/S linker and a
Leu-zipper from the yeast GCN4 protein (residues 250–281,
Uniprot accession number: P03069). The Leu-zipper segment
was obtained by a PCR reaction from yeast cDNA library [69].
In a subsequent step the pTac promoter was replaced with a
PhoA promoter by replacing a cassette between the EcoRI and
NsiI sites of the pTFBL-p3 vector with a cassette between the
same sites from the phGHR(1–238) vector [42], which was a
generous gift from Genentech. This final step resulted in the
vector pPFBL-p3 which is illustrated in Figure 1A.
Figure 7. Functional distribution of 41 known (A) and 110 predicted (B) binding partners of DYNLL. Data were collected from the
functional and Gene Ontology annotations of UniProt entry for each protein.
doi:10.1371/journal.pone.0018818.g007
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The library was produced based on previously described
protocols [70]. In the pPFBL-p3 vector the Bmf octapeptide
coding segment was replaced by 8 consecutive TAA stop codons
by Kunkel mutagenesis [68] resulting in the pPF-STOP-L-p3
vector. This vector served as a stop template for Kunkel
mutagenesis, when stop codons were replaced with the following
segment: NNK NNK NNK NNK NNK CAG NNK NNK. The
NNK codons represent a set of 32 codons covering all 20 amino
acid residues. CAG codes for glutamine. The resulted pPF-Lib-p3
library construct is illustrated in Figure 1B and C.
Phage display
All steps of the phage display selection and analysis of
individual peptide-displaying clones were carried out as previ-
ously described [70]. At first DYNLL1 was immobilized onto
MaxiSorp plates (NUNC), but the immobilization efficiency was
poor. The amount of properly folded immobilized homodimer
DYNLL1 was increased by using the GST-fused form. The
increased yield might have been due to two factors. Larger
proteins immobilize better on the MaxiSorp plate and GST is a
homodimer, which as a tag, appears to stabilize the homodimer
state of DYNLL1 [71]. To prevent selection of GST-binding
peptides, the peptide-phage solution was supplemented with
30 mg/ml recombinant GST. Two independent selections on two
different targets were performed. Nunc MaxiSorp ELISA plates
were coated with GST-DYNLL1 (3 mg/ml) or anti-Flag tag
antibody (2 mg/ml; SIGMA, F3165), respectively. Three selection
rounds were carried out on each target separately as described.
The eluted phage population was amplified in XL1 Blue cells
superinfected with helper phage. Binding properties of individual
peptide-phage clones were tested in a phage-ELISA format as
described [70].
Sequence analysis
The genes of individual peptide-phage clones producing an
ELISA signal on their target 3-fold above background (measured
on BSA or casein containing wells) were sequenced by the Big Dye
Terminator v3.1 cycle Sequencing Kit (Applied Biosystems). To
eliminate the effects of display bias, the amino acid frequencies
determined for DYNLL1-binding peptide-phage population were
normalized to data from the anti-Flag tag selected population. At
each randomized position, the positional amino acid frequencies
from the DYNLL-selected population were normalized to the
positional frequencies of amino acids determined in the anti-Flag
tag selected population. Sequences of the DYNLL-selected and the
anti-Flag tag selected clones are listed in Table S2 and S3,
respectively. For logo representation of the normalized results an
input sequence dataset containing 100 sequences was generated
representing the normalized amino acid frequencies at each
randomized positions. Sequence logos were generated by the
online application, WebLogo [44] available at http://weblogo.
berkeley.edu/logo.cgi.
Isothermal titration calorimetry
All peptides and DYNLL1 were dialyzed overnight in PBS
buffer supplemented with 3 mM 2-mercaptoethanol (pH 7.4). A
typical binding experiment involved 15 mM DYNLL1 in the cell
and 30–40 injections varying between of 3–5 ml peptide solution.
For each experiment the thermodynamic parameters were
determined at 299 K. We used a VP-ITC instrument from
Microcal and the data were fitted by the software package Origin
5.0 (OriginLab) using the simple A + B to AB binding model. The
signal from an initial 2 ml injection was eliminated. The
equilibration time between injections was 900 sec.
Crystallographic studies
DYNLL2 was dialyzed twice against TBS (20 mM TRIS-HCl,
1 5 0m M N a C l , 3m M N a N 3, 5 mM DTT, pH 7.6) and
concentrated using Amicon Ultra-4 Centrifugal Filter Unit with
Ultracel-3 membrane (Millipore). The Ac-SRGTQTE peptide
and the dimerized-VSRGTQTE peptide were dissolved in the
same buffer and subsequently complexed with DYNLL2. In the
final solutions of the complexes the Ac-SRGTQTE concentration
was 2.0 mM, the dimerized-VSRGTQTE concentration was
1.3 mM, while the concentration of dimeric DYNLL2 was
1.5 mM and 1.2 mM, respectively. Crystals were grown using the
hanging drop method at 293 K with a reservoir solution of 31%
PEG4000, 0.4 M CH3COONH4,0 . 1MC H 3COONa pH 4.6 in
the case of the Ac-SRGTQTE complex and 20% PEG8000,
0.2 M MgCl2, 0.1 M TRIS pH 7.0 in the case of the dimerized-
VSRGTQTE complex. Drops were composed of 2 ml reservoir
solution and 2 ml protein solution. The crystals were soaked in
reservoir solution plus 20% glycerol for 1 minute and subse-
quently flash frozen in liquid nitrogen.
X-ray diffraction data were collected from a crystal of the Ac-
SRGTQTE complex at 100 K with an ADSC Q315R CCD
detector at ID29 of the ESRF (l=0.93 A ˚). Data were indexed,
integrated and scaled to a resolution of 1.31 A ˚ using XDS and
XSCALE [72]. The space group is P212121 with unit cell
dimensions of a=35.6 A ˚, b=64.0 A ˚, c=151.8 A ˚. Data collection
of the crystal of the dimerized GSVSRGTQTE complex was
carried out using a Rigaku R-AXIS IV++ detector with Cu Ka
radiation (l=1.5418 A ˚) focused by Osmic confocal optics. Data
were indexed, integrated and scaled to 2.9 A ˚ resolution using the
CrystalClear software from Rigaku. The space group is P212121
with unit cell dimensions a=53.8 A ˚, b=68.4 A ˚, c=101.7 A ˚.
The structure of the DYNLL2/Ac-SRGTQTE peptide
complex was solved by molecular replacement using the
program PHASER [73] of CCP4 6.1.2 Program Suite [74,75].
As search model, the structure of 1CMI was used, thereafter
automated model building was carried out with Arp/wArp [76]
using amino acid sequences of both DYNLL2 monomer and the
synthetic peptide Ac-SRGTQTE. The model was systematically
improved using iterative cycles of manual rebuilding with the
program Coot [77] and refinement with Refmac5 of CCP4
6.1.2 Program Suite [74,75]. At the final steps of refinement
restrained anisotropic temperature factors for the protein atoms
were introduced and this step reduced Rfactor and Rfree by 2.4%
and 1.5% respectively. During the automated model building,
419 water molecules were modeled and the final refined
structure had overall Rcryst=12.1% and Rfree=15.6%. The
structure of the DYNLL2/Leu-zipper dimerized GSVS
RGTQTE peptide complex wass o l v e du s i n gt h eM O L R E P
program off the CCP4 package [78]. The DYNLL2/Ac-
SRGTQTE complex structure was used as search model.
Model building was carried out using the program Coot [77].
The model was refined with Refmac5 [75] using restrained
maximum-likelihood refinement and TLS refinement [79].
During refinement non-crystallographic restraints were added
t ot h eD Y N L L 2m o l e c u l e so ft h ed i m e ra sw e l la st ot h eb o u n d
segment and coiled coil region of the engineered peptide. The
final model contains 1999 atoms and 40 water molecules and it
has overall Rcryst=25.0% and R free=29.5%. The stereochem-
istry of the structures was assessed with WHATCHECK [80]
and PROCHECK [81]. The structures were deposited with the
PDB under reference codes 2XQQ and 3P8M, respectively.
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Table S4.
Binding partner prediction
For binding partner prediction a simple scoring matrix was used
containing display-normalized position-specific percentages of
each amino acid type of the selected sequence set. The score
equals the summed up occurrences along the eight residue motif
(Eq. 1).
S~
X 8
i~1
vN
i {100 ð1Þ
S is the score of the eight residue motif, nN
i is the percentage
occurrence of amino acid N in the i
th position in the selected
sequence set. Subtraction of 100 stands for eliminating the score
contribution of the nonrandomized Gln at position 0. The input
dataset was a filtered subset of the annotated human protein
sequence set from UniProt [82]. Secreted proteins, transmem-
brane and extracellular domains of membrane proteins were
excluded. From the remaining intracellular set only predicted
disordered regions were used. A score value was assigned to each
eight residue segment if at least one residue of the segment was
predictedly unstructured and if the segment contained a Gln at
position 0. For disorder prediction we used IUPred [83] as
proposed by a recent comparative study [84]. The prediction
program was implemented in Perl and is freely available with the
scoring matrix upon request. (For an overview of binding site
prediction see Figure 5.)
We determined the threshold as follows: we generated 1000
scoring matrices by keeping the original phage selected matrix
scores at each position but randomized the positions themselves.
Using the same input sequence set, we repeated the above
described scoring with all randomized matrices. To calculate the
probability density function, hits were summed up for ten score
unit windows. Density distribution function values generated by
the real phage selected scoring matrix were normalized by the
averages of corresponding values obtained by the randomized
matrices. Threshold was defined as a score value above which the
normalized distribution function values exceed one.
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